104 related articles for article (PubMed ID: 38951880)
1. Using digital technology to reduce drug-related harms: a targeted service users' perspective of the Digital Lifelines Scotland programme.
Strachan G; Daneshvar H; Carver H; Greenhalgh J; Matheson C
Harm Reduct J; 2024 Jul; 21(1):128. PubMed ID: 38951880
[TBL] [Abstract][Full Text] [Related]
2. "You know, we can change the services to suit the circumstances of what is happening in the world": a rapid case study of the COVID-19 response across city centre homelessness and health services in Edinburgh, Scotland.
Parkes T; Carver H; Masterton W; Falzon D; Dumbrell J; Grant S; Wilson I
Harm Reduct J; 2021 Jun; 18(1):64. PubMed ID: 34118942
[TBL] [Abstract][Full Text] [Related]
3. A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: the SHARPS feasibility mixed-methods study.
Parkes T; Matheson C; Carver H; Foster R; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; MacLennan G
Health Technol Assess; 2022 Feb; 26(14):1-128. PubMed ID: 35212621
[TBL] [Abstract][Full Text] [Related]
4. 'They already operated like it was a crisis, because it always has been a crisis': a qualitative exploration of the response of one homeless service in Scotland to the COVID-19 pandemic.
Parkes T; Carver H; Masterton W; Falzon D; Dumbrell J; Grant S; Wilson I
Harm Reduct J; 2021 Mar; 18(1):26. PubMed ID: 33658042
[TBL] [Abstract][Full Text] [Related]
5. 'It was like coming back from the clouds': a qualitative analysis of the lived experience of overdose consequent to drug use among a cohort of people who use drugs in Scotland.
Byrne CJ; Sani F; Flynn T; Malaguti A
Harm Reduct J; 2024 Jun; 21(1):112. PubMed ID: 38849877
[TBL] [Abstract][Full Text] [Related]
6. A practice research study concerning homeless service user involvement with a programme of social support work delivered in a specialized psychological trauma service.
Archard PJ; Murphy D
J Psychiatr Ment Health Nurs; 2015 Aug; 22(6):360-70. PubMed ID: 26177734
[TBL] [Abstract][Full Text] [Related]
7. Contested space in the pharmacy: public attitudes to pharmacy harm reduction services in the West of Scotland.
Gidman W; Coomber R
Res Social Adm Pharm; 2014; 10(3):576-87. PubMed ID: 24021859
[TBL] [Abstract][Full Text] [Related]
8. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
Wallace B; van Roode T; Pagan F; Phillips P; Wagner H; Calder S; Aasen J; Pauly B; Hore D
Harm Reduct J; 2020 May; 17(1):29. PubMed ID: 32398090
[TBL] [Abstract][Full Text] [Related]
9. Assessing the feasibility, acceptability and accessibility of a peer-delivered intervention to reduce harm and improve the well-being of people who experience homelessness with problem substance use: the SHARPS study.
Parkes T; Matheson C; Carver H; Foster R; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; Price T; Schofield J; MacLennan G
Harm Reduct J; 2022 Feb; 19(1):10. PubMed ID: 35120539
[TBL] [Abstract][Full Text] [Related]
10. Homeless drug users and information technology: a qualitative study with potential implications for recovery from drug dependence.
Neale J; Stevenson C
Subst Use Misuse; 2014 Sep; 49(11):1465-72. PubMed ID: 24799073
[TBL] [Abstract][Full Text] [Related]
11. A critical narrative inquiry to understand the impacts of an overdose prevention site on the lives of site users.
Oudshoorn A; Sangster Bouck M; McCann M; Zendo S; Berman H; Banninga J; Le Ber MJ; Zendo Z
Harm Reduct J; 2021 Jan; 18(1):6. PubMed ID: 33407553
[TBL] [Abstract][Full Text] [Related]
12. Using drugs alone in single room occupancy housing: Understanding environmental drivers of overdose risk.
Fleming T; Boyd J; Gagnon M; Kerr T; McNeil R
Int J Drug Policy; 2024 Jun; 128():104444. PubMed ID: 38754243
[TBL] [Abstract][Full Text] [Related]
13. Overdose responses among rural people who use drugs: A multi-regional qualitative study.
Baker R; Fredericksen RJ; Rudolph AE; Stopka TJ; Walters SM; Fadanelli M; Bolinski RS; Sibley AL; Stack E; Crane HM; Korthuis PT; Seal DW
Harm Reduct J; 2024 May; 21(1):107. PubMed ID: 38822387
[TBL] [Abstract][Full Text] [Related]
14. People who use drugs engagement in substance use disorder services and harm reduction: evaluation, challenges and future direction of a community-based intervention.
Gleason-Comstock J; Calhoun CB; Locke BJ; Boorle NVLD; Cobty K; McKenney T; Uddin KO; Bauer SJ; Xu J
Subst Abuse Treat Prev Policy; 2024 Apr; 19(1):24. PubMed ID: 38689339
[TBL] [Abstract][Full Text] [Related]
15. The acceptability of overdose alert and response technologies: introducing the TPOM-ODART framework.
Dumbrell J; Daneshvar H; Oteo A; Baldacchino A; Matheson C
Harm Reduct J; 2023 Mar; 20(1):40. PubMed ID: 36967388
[TBL] [Abstract][Full Text] [Related]
16. The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study.
Schofield J; Dumbrell J; Matheson C; Parkes T; Bancroft A
BMC Public Health; 2022 Mar; 22(1):500. PubMed ID: 35287630
[TBL] [Abstract][Full Text] [Related]
17. A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts.
Hassan R; Roland KB; Hernandez B; Goldman L; Evans KN; Gaul Z; Agnew-Brune C; Buchacz K; Fukuda HD
J Subst Abuse Treat; 2022 Jul; 138():108722. PubMed ID: 35067399
[TBL] [Abstract][Full Text] [Related]
18. Understanding the use of digital technologies to provide disability services remotely during the COVID-19 pandemic; a multiple case study design.
Fortune J; Manikandan M; Harrington S; Hensey O; Kerr C; Koppe S; Kroll T; Lavelle G; Long S; MacLachlan M; Nolan D; Norris M; O'Reilly J; Owens M; Walsh A; Walsh M; Ryan JM
BMC Health Serv Res; 2024 Mar; 24(1):323. PubMed ID: 38468253
[TBL] [Abstract][Full Text] [Related]
19. Exploring the factors that influence the decision to adopt and engage with an integrated assistive telehealth and telecare service in Cambridgeshire, UK: a nested qualitative study of patient 'users' and 'non-users'.
Cook EJ; Randhawa G; Sharp C; Ali N; Guppy A; Barton G; Bateman A; Crawford-White J
BMC Health Serv Res; 2016 Apr; 16():137. PubMed ID: 27095102
[TBL] [Abstract][Full Text] [Related]
20. Perceptions about supervised injection facilities among people who inject drugs in Philadelphia.
Harris RE; Richardson J; Frasso R; Anderson ED
Int J Drug Policy; 2018 Feb; 52():56-61. PubMed ID: 29241143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
